Evolution of liver antioxidant status and iron implication during the development of deoxycorticosterone-saline hypertension in rats

Biological Trace Element Research

Volumn 107, Issue 3, 2005, Pages 263-276

  Elhaïmeur, Fatiha ^a   Nicod, Laurence ^a   Courderot Masuyer, Carol ^a   Robin, Sophie ^a   Guyon, Catherine ^a   Bouhaddi, Malika ^a   Regnard, Jacques ^a   Richert, Lysiane ^a   Berthelot, Alain ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

DOCA salt hypertension development; Iron; Lipid peroxidation; Liver antioxidant status; Nitric oxide

Indexed keywords

DEOXYCORTICOSTERONE; IRON; OXIDOREDUCTASE; PEROXIDASE; TRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CHELATION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; HYPERTENSION; MALE; MOLECULAR EVOLUTION; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CYTOSOL; DESOXYCORTICOSTERONE; GLUTATHIONE; HYPERTENSION; IRON; LIVER; NITRIC OXIDE; OXIDANTS; OXIDATIVE STRESS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TRACE ELEMENTS;

ANIMALIA;

EID: 27844572919     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:107:3:263     Document Type: Article

References (49)

1. D. J. DiPette, Experimental models of hypertension, in Hypertension Primer, J. L. Izzo and H. R. Black, eds., American Heart Association, Dallas, TX, pp. 95-97 (1993).
2. J. Schenk and J. H. McNeill, The pathogenesis of DOCA-salt hypertension, J. Pharmacol Toxicol. Methods 27, 161-170 (1992).
3. K. Nakazono, N. Watanabe, K. Matsuno, et al., Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA 88, 10,045-10,048 (1991).
4. P. Johnson, Antioxidant enzyme expression in health and disease: effects of exercise and hypertension, Comp. Biochem. Physiol. 133C, 493-505 (2002).
5. B. Frei, On the role of vitamine C and other antioxidants in atherogenesis and vascular dysfunction, Proc. Soc. Exp. Biol. Med. 222, 196-204 (1999).
6. N. D. Vaziri, X. Q. Wang, F. Oveisi, et al., Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats, Hypertension 36, 142-146 (2000).
7. C. Russo, O. Olivieri, D. Girelli, et al., Anti-oxidant status and lipid peroxidation in patients with essential hypertension, J. Hypertens. 16(9), 1267-1271 (1998).
8. B. Halliwell, Antioxidant defence mechanisms: from the beginning to the end (of the beginning), Free Radical Res. 31, 261-272 (1999).
9. L. Nicod, S. Rodriguez, J. M. Letang, et al., Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague-Dawley rats, Mol. Cell. Biochem. 203, 33-39 (2000).
10. D. Binda, L. Nicod, C. Viollon-Abadie, et al., Strain difference (WKY, SPRD) in the liver antioxidant status in rat and effect of hypertension (SHR, DOCA). Ex vivo and in vitro data, Mol. Cell. Biochem. 218, 139-146 (2001).
11. F. Elhaïmeur, C. Courderot-Masuyer, L. Nicod, et al., Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive rat male Sprague-Dawley rats and this is associated with increased liver oxidative stress, Mol. Cell. Biochem. 237, 77-83 (2002).
12. R. J. Gryglewski, R. M. J. Palmer, and S. Moncada, Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature. 320, 454-456 (1986).
13. D. W. Laight, A. V. Kaw, M. J. Carrier, et al., Interaction between superoxide anion and nitric in the regulation of vascular endothelial function, Br. J. Pharmacol. 124, 238-244 (1998).
14. B. S. Polla, Therapy by taking away: the case of iron, Biochem. Pharmacol. 12, 1345-1349 (1999).
15. S. Park and J. A. Imlay High levels of intracellular cysteine promote oxidative DNA damage by driving the Fenton reaction, J. Bacteriol. 185(6), 1942-1950 (2003).
16. F. Elhaïmeur, C. Courderot-Masuyer, L. Nicod, et al., Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats, Can. J. Physiol. Pharmacol. 81, 469-475 (2003).
17. A. Chang and G. R. Fink, Metal ion metabolism. The copper-iron connection, Curr. Biol. 4(6), 532-533 (1994).
18. L. Nicod, S. Rodriguez, A. Jacqueson, et al., Clofibric acid or diethylmaleate supplemented diet decrease blood pressure in DOCA-salt male Sprague-Dawley rats. Relation with liver antioxidant status, Mol. Cell. Biochem. 213, 65-73 (2000).
19. P. K. Smith, R. I. Krohn, G. T. Hermanson, et al., Measurement of protein using bicin-choninic acid, Anal. Biochem. 150, 76-85 (1985).
20. H. Ohkawa, N. Ohishi, and K. Yagi, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem. 95, 351-358 (1979).
21. O. W. Griffith, Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine, Anal. Biochem. 106, 207-212 (1980).
22. K. G. Allen and J. R. Arthur, Inhibition by 5-sulphosalicylic acid of the glutathione reductase recycling assay for glutathione analysis, Clin. Chim. Acta 162, 237-239 (1987).
23. R. A. Lawrence and R. F. Burk, Glutathione peroxidase activity in selenium-deficient rat liver, Biochem. Biophys. Res. Commun. 71, 952-958 (1976).
24. H. Aebi, Catalase in vitro, Methods Enzymol. 105, 121-126 (1984).
25. J. M. McCord and I. Fridovich, Superoxide dismutase, an enzymatic function for erythrocuprein, J. Biol. Chem. 244, 6049-6055 (1989).
26. L. Flohé and F. Otting, Superoxide dismutase assays, Methods Enzymol. 105, 93-104 (1984).
27. I. Carlberg and B. Mannervik, Glutathione reductase, Methods Enzymol. 113, 484-490 (1985).
28. G. Bellomo, F. Mirabelli, D. Dimonte, et al., Formation and reduction of glutathione mixed disulfides during oxidative stress, Biochem. Pharmacol. 36, 1313-1320 (1987).
29. W. H. Habig, J. M. Pabst, and W. B. Jakobi, Glutathione-S-transferases, J. Biol. Chem. 249, 7130-7139 (1974).
30. S. L. Archer, Measurement of nitric oxide in biological models, FASEB J. 7, 349-360 (1993).
31. H. Kurumatani, K. Kikuchi, T. Nagano, et al., Real time measurement of nitric oxide released from cultured endothelial cells, Biol. Pharmacol. Bull. 21, 1286-1289 (1998).
32. S. Rodriguez, A. Bidet, A. Berthelot, et al., Arginase activity and manganese content in various tissues from control and DOCA-salt hypertensive male Sprague-Dawley rats, Trace Elements Elec. 15, 181-184 (1998).
33. S. Bobillier-Chaumont, V. Maupoil, J. J. Lahet, et al., Effect of exercise training on metallothionein levels of hypertensive rats, Med. Sci. Sports Exerc. 33, 724-728 (2001).
34. S. Rodriguez, L. Richert, and A. Berthelot, Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats, Clin. Exp. Hypertens. 22(1), 75-85 (2000).
35. D. L. Gilbert, Fifty years of radical ideas, in Reactive Oxygen Species from Radiation to Molecular Biology, Annals of the New York Academy of Sciences Vol. 899, C. C. Chieuh, ed., New York Academy of Sciences, New York, pp. 1-14 (2000).
36. N. D. Vaziri, K. Liang, and Y. Ding, Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension, Kidney Int. 56(4), 1492-1498 (1999).
37. B. Halliwell, What nitrates tyrosine? Is nitrotyrosine specific as a biomaeker of peroxinitrite formation in vivo? FEBS Lett. 411, 157-160 (1997).
38. V. Darley-Usmar and B. Halliwell, Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system, Pharm. Res. 13, 649-662 (1996).
39. H. Ito, M. Torii, and T. Suzuki, A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium, Comp. Biochem. Physiol. B 103, 37-40 (1992).
40. J. Pedro-Botet, M. I Covas, S. Martin, et al., Decreased endogenous antioxidant enzymatic status in essential hypertension, J. Hum. Hypertens. 14, 343-345 (2000).
41. C. Demougeot, C. Marie, and A. Beley Importance of iron location in iron-induced hydroxyl radial production by brain slices, Life Sci. 67, 399-410 (2000).
42. M. J. Burkitt and B. C. Gilbert, The autoxidation of iron(II) in aqueous systems: the effects of iron chelation by physiological, non-physiological and therapeutic chelators on the generation of reactive oxygen species and the inducement of biomolecular damage, Free Radical Res. Commun. 14(2), 107-123 (1991).
43. J. M. Gutteridge and B. Halliwell, Free radicals and antioxidants in the year 2000. A historical look to the future, Ann. Ann Acad. Sci. 899, 136-147 (2000).
44. M. Oubidar, M. Boquillon, C. Marie, et al., Effect of intracellular iron loading on lipid peroxidation of brain slices, Free Radical Biol. Med. 21(6), 763-769 (1996).
45. Y. V. Yuan, D. D. Kitts, and D. V. Godin, Heart and red blood cell antioxidant status and plasma lipid levels in the spontaneously hypertensive and normotensive Wistar-Kyoto rat, Can. J. Physiol. Pharmacol. 74(3), 290-297 (1996).
46. K. S. Cabell, L. Ma, and P. Johnson, Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels, Biochem. Pharmacol. 54(1), 133-141 (1997).
47. C. Vergely A. Tabard, V. Maupoil, et al., Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury: cardiovascular effects of the spin trap alpha-phenyl N-tert-butylnitrone, Free Radical Res. 35, 475-489 (2001).
48. S. M. Turbino-Ribeiro, M. E. Silva, D. A. Chianca, Jr., et al., Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure, J. Nutr. 133(1), 15-20 (2003).
49. L. Gambling, S. Dunford, D. I. Wallace, et al., Iron deficiency during pregnancy affects postnatal blood pressure in the rat, J. Physiol. 552(Pt. 2), 603-610 (2003).